← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and General Counsel Karah Herdman Parschauer sold $192K of Ultragenyx Pharmaceutical Inc.

Sold$192,265
$66.62Price
2,886Shares
−7%Stake

What RARE did after the filing

Filed Mar 3Copier in Mar 4
The stock from Fri, Mar 4 open, $63.07
+24.4%
S&P 500, same days
+1.8%

Measured over 30 trading days, to the Apr 18 close.

Traded Tue, Mar 1. Filed Thu, Mar 3, 6:08 PM ET, after the close. Returns use the Mar 4 open and the Apr 18 close. Not investment advice.